JP2023526923A5 - - Google Patents
Info
- Publication number
- JP2023526923A5 JP2023526923A5 JP2022569264A JP2022569264A JP2023526923A5 JP 2023526923 A5 JP2023526923 A5 JP 2023526923A5 JP 2022569264 A JP2022569264 A JP 2022569264A JP 2022569264 A JP2022569264 A JP 2022569264A JP 2023526923 A5 JP2023526923 A5 JP 2023526923A5
- Authority
- JP
- Japan
- Prior art keywords
- raav
- pharmaceutical composition
- patient
- composition according
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063024941P | 2020-05-14 | 2020-05-14 | |
| US63/024,941 | 2020-05-14 | ||
| US202063109677P | 2020-11-04 | 2020-11-04 | |
| US63/109,677 | 2020-11-04 | ||
| US202163180379P | 2021-04-27 | 2021-04-27 | |
| US63/180,379 | 2021-04-27 | ||
| PCT/US2021/032451 WO2021231863A1 (en) | 2020-05-14 | 2021-05-14 | Compositions useful for treatment of pompe disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023526923A JP2023526923A (ja) | 2023-06-26 |
| JP2023526923A5 true JP2023526923A5 (cg-RX-API-DMAC7.html) | 2024-05-23 |
Family
ID=78525047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022569264A Pending JP2023526923A (ja) | 2020-05-14 | 2021-05-14 | ポンペ病の治療に有用な組成物 |
Country Status (13)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024003687A1 (en) * | 2022-06-28 | 2024-01-04 | Pfizer Inc. | Nucleic acids encoding acid alpha-glucosidase (gaa) and vectors for gene therapy |
| US20260216373A1 (en) * | 2023-01-13 | 2026-07-30 | Amicus Therapeutics, Inc. | Gene Therapy Constructs for the Treatment of Pompe Disease |
| WO2026072802A1 (en) * | 2024-09-26 | 2026-04-02 | University Of Connecticut | Perinuclear targeting by gene therapies for cardiopathology |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007322123A1 (en) * | 2006-11-13 | 2008-05-29 | Biomarin Pharmaceutical Inc. | Methods for treating Pompe disease |
| US20120322861A1 (en) * | 2007-02-23 | 2012-12-20 | Barry John Byrne | Compositions and Methods for Treating Diseases |
| KR20200032244A (ko) * | 2012-03-07 | 2020-03-25 | 아미쿠스 세라퓨틱스, 인코포레이티드 | 폼페병의 치료를 위한 고농도 알파-글루코시다제 조성물 |
| AU2015208247B2 (en) * | 2014-01-21 | 2021-05-27 | Universiteit Gent | Muscle-specific nucleic acid regulatory elements and methods and use thereof |
| CA2947466A1 (en) * | 2014-05-01 | 2015-11-05 | University Of Washington | In vivo gene engineering with adenoviral vectors |
| EP2960336A1 (en) * | 2014-06-27 | 2015-12-30 | Genethon | Efficient systemic treatment of dystrophic muscle pathologies |
| WO2018178067A1 (en) * | 2017-03-27 | 2018-10-04 | Vrije Universiteit Brussel | Diaphragm-specific nucleic acid regulatory elements and methods and use thereof |
| DK3684423T5 (da) * | 2017-09-20 | 2024-08-26 | 4D Molecular Therapeutics Inc | Adeno-associerede virusvariantcapsider og fremgangsmåder til anvendelse deraf |
| TW202344691A (zh) * | 2018-04-30 | 2023-11-16 | 美商阿米庫斯醫療股份有限公司 | 基因治療構築體及使用方法 |
| US20220193261A1 (en) * | 2019-04-30 | 2022-06-23 | The Trustees Of The University Of Pennsylvania | Compositions useful for treatment of pompe disease |
-
2021
- 2021-05-14 EP EP21804731.4A patent/EP4149519A4/en not_active Withdrawn
- 2021-05-14 WO PCT/US2021/032451 patent/WO2021231863A1/en not_active Ceased
- 2021-05-14 MX MX2022014255A patent/MX2022014255A/es unknown
- 2021-05-14 BR BR112022022704A patent/BR112022022704A2/pt not_active IP Right Cessation
- 2021-05-14 AU AU2021273273A patent/AU2021273273A1/en not_active Abandoned
- 2021-05-14 JP JP2022569264A patent/JP2023526923A/ja active Pending
- 2021-05-14 US US17/998,371 patent/US20230173108A1/en not_active Abandoned
- 2021-05-14 IL IL298178A patent/IL298178A/en unknown
- 2021-05-14 CN CN202180049054.5A patent/CN115916334A/zh active Pending
- 2021-05-14 CA CA3177954A patent/CA3177954A1/en active Pending
- 2021-05-14 KR KR1020227043641A patent/KR20230010255A/ko not_active Withdrawn
-
2022
- 2022-11-10 CL CL2022003132A patent/CL2022003132A1/es unknown
- 2022-11-30 CO CONC2022/0017224A patent/CO2022017224A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111718947B (zh) | 用于治疗ⅲa或ⅲb型粘多糖贮积症的腺相关病毒载体及用途 | |
| JP2022530833A5 (cg-RX-API-DMAC7.html) | ||
| US12171794B2 (en) | Gene therapy for ciliopathies | |
| IL282053B2 (en) | Constructions of glut1-linked recombinant aav vectors, preparations and kits containing them and their use | |
| SG11202111400TA (en) | Compositions useful for treatment of pompe disease | |
| JP2022530824A5 (cg-RX-API-DMAC7.html) | ||
| US20020076754A1 (en) | Overcoming AAV vector size limitation through viral DNA hetero-dimerization | |
| JP2020526514A5 (cg-RX-API-DMAC7.html) | ||
| JP2022512589A5 (cg-RX-API-DMAC7.html) | ||
| CA3173768A1 (en) | Viral vector constructs for delivery of nucleic acids encoding cytokines and uses thereof for treating cancer | |
| JP2023503850A5 (cg-RX-API-DMAC7.html) | ||
| EP4509606A1 (en) | Nucleic acid construct for treating hereditary coagulation factor deficiency and use thereof | |
| US20230220420A1 (en) | Gene therapy for bardet-biedl syndrome | |
| EP4368203A1 (en) | Construction and use of anti-vegf antibody in-vivo expression system | |
| IL324272A (en) | Chimeric modified ion channels and uses thereof for treatment of trigeminal nerve disorders | |
| KR20220027829A (ko) | 심장보호 활성 갖는 단백질 | |
| JP2023551254A5 (cg-RX-API-DMAC7.html) | ||
| JP2022530359A5 (cg-RX-API-DMAC7.html) | ||
| JP2022523050A5 (cg-RX-API-DMAC7.html) | ||
| CN116656704A (zh) | 用于治疗法布里病的转基因表达盒 | |
| CN118871459A (zh) | 新型蛋白质和核酸序列及其在预防和/或治疗先天性肌营养不良症中的用途 | |
| US20240076691A1 (en) | Codon-optimized nucleic acid encoding the fix protein | |
| HK40096161A (en) | Nucleic acid construct for treatment of hereditary coagulation factor deficiency disease and use thereof | |
| HK40096161B (en) | Nucleic acid construct for treatment of hereditary coagulation factor deficiency disease and use thereof | |
| HK40108451A (en) | A nucleic acid construct for treating hereditary coagulation factor deficiency |